Search Results 521-530 of 18344 for total bilirubin

  1. Identify Exomic Alterations that Contribute to the Development of Liver Disease - Mayo Clinic

    Unexplained cholestatic liver disease. Definition: Persistently or intermittently elevated alkaline phosphatase and/or total bilirubin AND negative anti ...

  2. A Study of the Use of a New Drug in People with Non-Alcoholic Steatohepatitis (NASH) or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    Participation eligibility · Age: 21-75 years old. · Body Mass Index (BMI) >19kg/m2. · Subjects with biopsy/MRE proven NASH [MRS liver fat ≥ 5%. · Total bilirubin ( ...

  3. Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma - Mayo Clinic

    Whole brain MRI with and without gadolinium and spine MRI with gadolinium ... Total or direct bilirubin ≤ 1.5 x upper limit of normal (ULN) for age; and ...

  4. A Study of ONC201 for Patients with H3 K27M-mutant and/or Midline High Grade Gliomas - Mayo Clinic

    Total serum bilirubin < 1.5 X upper limit of normal (ULN);; AST (SGOT)/ALT (SGPT) ≤ 2 X ULN; ≤ 5 X ULN if there is liver involvement secondary to tumor; ...

  5. Testing The Use Of Neratinib Or The Combination Of Neratinib And Palbociclib Targeted Treatment For HER2+ Solid Tumors (A ComboMATCH Treatment Trial) - Mayo Clinic

    Total bilirubin level ≤ 1.5 x institutional upper limit of normal (ULN) (patients with known Gilbert's disease who have bilirubin level ≤ 3 x ...

  6. A Study Of Alcohol Use In Alcohol-associated Liver Disease - Mayo Clinic

    Onset of jaundice (defined as serum total bilirubin >3 mg/dL) within the prior 8 weeks. Ongoing consumption of > 40 gm (for females) and > 60 gm (for males) ...

  7. Lenalidomide and AT-101 in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia - Mayo Clinic

    Total bilirubin ≤ 1.5 mg/dL or direct bilirubin ≤ 1.0mg/dL for patients with Gilberts syndrome; Aspartate aminotransferase (AST) (serum glutamic ...

  8. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

    > 2.0 × ULN of any of the following: ALT, AST, ALP, or > ULN total bilirubin (> 1.5 × ULN total bilirubin if known Gilbert's syndrome). Other Exclusions.

  9. A Study of the Effectiveness and Safety of CTL019 in Adult Patients with Diffuse Large B-Cell Lymphoma - Mayo Clinic

    ... total bilirubin is ≤ 3.0 x ULN and direct bilirubin ≤ 1.5 x ULN. Must have a minimum level of pulmonary reserve defined as ≤ Grade 1 dyspnea and pulse ...

  10. A Study to Evaluate KIN-3248 in Participants With Advanced Tumors Harboring FGFR2 and//or FGFR3 Gene Alterations - Mayo Clinic

    Serum total bilirubin ≤ 1.5 x ULN (< 3.0 x ULN for participants with documented Gilbert's syndrome);; ALP ≤ 2.5 x ULN (≤ 5 x ULN in case of bone ...